Vinergy Resources/MJ BioPharma to Acquire 65% of Health Canada and FDA Licensed Laboratory to Pursue Drug Testing and Dosage of CBDs, THC and Terpenes
9:55 AM February 22, 2017VANCOUVER, BRITISH COLUMBIA, VNNYF,–(Marketwired – Feb 22, 2017) – Vinergy Resources Ltd. (“Vinergy” or the “Company”) (CSE:VIN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ BioPharma (announced December 14, 2016) is pleased to announce that, as a part of the Company’s strategy to develop products that test and identify specific cannabinoid isolates for targeted therapeutic purposes it has signed a binding Letter of Intent (“LOI”) to acquire 65% of Biolennia Laboratories Inc. (the “Laboratory”). Biolennia will provide a host of
Read more